Clinical Trial

Patients Diagnosed With Scleroderma: Physical Performance and Functionality

Recruiting
View on ClinicalTrials.gov →
Summary
Physical functionality and performance are important for individuals diagnosed with scleroderma. There is a need to address children and adults diagnosed with scleroderma comprehensively and to evaluate them on a biopsychosocial basis to support their disease management. In light of all this literature, the aim was to evaluate the biopsychosocial characteristics of both pediatric and adult scleroderma patients and to examine their physical performance and functionality. Additionally, this study aims to identify effective tests that can be used in future research to assess physical performance and functionality in individuals diagnosed with scleroderma.
Trial Details
NCT Number NCT07183072
Lead Sponsor Hacettepe University
Conditions Systemic Sclerosis (SSc), Scleroderma, Scleroderma (Limited and Diffuse), Scleroderma, Localized, Functionality
Enrollment 50 participants
Start Date 2025-08-04
Primary Completion 2027-08 (estimated)
Study Completion 2027-08-04 (estimated)
Updated on ClinicalTrials.gov 2025-09-19